Status:
COMPLETED
PKU Skin Stripping
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborating Sponsors:
BioMarin Pharmaceutical
Conditions:
Phenylketonurias
Eligibility:
All Genders
Brief Summary
PURPOSE OF STUDY: To determine if a non-invasive skin stripping technique can be used to detect individuals with phenylalanine abnormalities, and to monitor dietary and/or drug effects over time.
Detailed Description
This study will determine if a non-invasive skin stripping technique can be used to detect individuals with phenylalanine abnormalities, and to monitor dietary and/or drug effects over time. To do thi...
Eligibility Criteria
Inclusion
- A clinical diagnosis of PKU that is confirmed by elevated serum phenylalanine.
- Any age.
- Subject or the subject's legal authorized representative has given written informed consent to participate in the study.
Exclusion
- Not applicable.
Key Trial Info
Start Date :
October 12 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT04368624
Start Date
October 12 2015
End Date
April 1 2021
Last Update
July 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229